参考文献/References:
[1] Jemal A, Siegel R, Ward E, et al.Cancer statistics, 2007.CA Caner J Clin, 2007, 57(1):43-66.
[2] Lee JH, Rosen EL, Mankoff DA.The role of radiotracer imaging in the diagnosis and management of patients with breast cancer:part1-overview, detection, and staging.J Nucl Med, 2009, 50(4):569-581.
[3] 赵亚平, 周世英, 刘荣波.等.乳腺X线片中成簇样微小钙化对乳腺癌的诊断价值.临床放射学杂志, 2001, 20(1):7-10.
[4] 汪敏, 彭绩, 许奕华, 等.超声检查、乳房X线摄影术在乳腺癌筛查和早期诊断中作用的Meta分析.疾病控制杂志, 2006, 10(1):33-34.
[5] Abe N, Schmidt RA, Sennett CA, et al.US-guided core needle biopsy of axillary lymph nodes in patients with breast cancer:why and how to do it.Radiographics, 2007, 27(suppl 1):S91-S99.
[6] 陈林丽, 赵建农, 郭大静, 等.1H-MRS联合DCE-MRI在乳腺痛中的应用价值.中国医学计算机成像杂志, 2008, 14(2):106-110.
[7] Mankoff DA, Dunnwald LK, Gralow JR, et al.[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow.Nucl Med Biol, 2002, 29(7):719-727.
[8] Liberman M, Sampalis F, Mulder DS, et al.Breast cancer diagnosis by scintimammography:a meta-analysis and review of the literature.Breast Cancer Res Treat, 2003, 80(1):115-126.
[9] Brem RF, Fishman M, Rapelyea JA.Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging, a comparative study.Acad Radiol,2007, 14(8):945-950.
[10] Brem RF, Floerkc AC, Rapelyea JA, et al.Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer.Radiology, 2008, 247(3):651-657.
[11] Longer I, Guller U, Berclaz G, et al.Mobidity of sentinel lymphnode biopsy (SLN) alone versus SLN and completion axillary lymph node dessection after breast cancer surgery:a prospective Swiss multicenter study on 659 patients.Ann Surg, 2007, 245(3):452-461.
[12] 李囡, 林保和, 欧阳涛, 等.467例乳腺癌患者99Tcm-利妥昔单抗前哨淋巴结显像结果分析.中华核医学杂志, 2009, 29(1):3-7.
[13] 周敏, 章英剑, 程竞仪.内乳前哨淋巴结99Tcm-硫胶体显像影响因素分析.中华核医学杂志, 2009, 29(1):8-11.
[14] Kumar R, Chauhan A, Zhuang H, et al.Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.Breast Cancer Res Treat, 2006, 98(3):267-274.
[15] Rosen EL, Eubank WB, Mankoff DA.FDG PET, PET/CT, and breast cancer imaging.Radiographics, 2007, 27(suppl 1):S215-S229.
[16] Raylman RR, Majewski S, Smith MF, et al.The positron emission mammography/tomography breast imaging and biopsy system(PEM/PET):design, construction and phantom-based measurem-ents.Phys Med Biol, 2008, 53(3):637-653.
[17] Wahl RL, Siegel BA, Coleman RE, et al.Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer:a report of the staging breast cancer with PET study group.J Clin Oncl, 2004, 22(2):277-285.
[18] Grant FD, Fahey FH, Packard AB, et al.Skeletal PET with 18F-fluoride:applying new technology to an old traccr.J Nucl Med,2008, 49(1):68-78.
[19] Fogelman I, Cook G, Isreal O, et al.Positron emission tomography and bone metastases.Semin Nucl Med, 2005, 35(2):135-142.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
[7]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[8]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[9]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[10]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[11]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[12]李雯,冯彦林.18F-FDG PET/CT评估三阴性乳腺癌新辅助化疗疗效的研究进展[J].国际放射医学核医学杂志,2014,38(3):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
Li Wen,Feng Yanlin.Advances of assessment with 18F-FDG PET/CT in triple-negative breast cancer during neoadjuvant chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
[13]胡梦裳,章斌.PET/CT显像在乳腺癌疗效评价及预后中的作用[J].国际放射医学核医学杂志,2014,38(5):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
Hu Meng-shang,Zhang Bin.The role of PET/CT imaging in the evaluation of the efficacy and prognosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
[14]王宇峰,刘海娜,张居洋,等.SPECT/CT融合显像对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
Wang Yu-feng,Liu Hai-na,Zhang Ju-yang,et al.Clinical value of SPECT/CT fusion imaging in diagnosing metastatic bone lesions in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
[15]董佳佳,章斌.多种影像学方法评价乳腺癌新辅助化疗疗效的价值比较[J].国际放射医学核医学杂志,2014,38(6):427.[doi:10.3760/cma.j.issn.1673-4114.2014.06.018]
Dong Jia-jia,Zhang Bin.Comparision on the values of different image modalities in monitoring the response to neoadjuvant chemotherapy in breast cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):427.[doi:10.3760/cma.j.issn.1673-4114.2014.06.018]
[16]袁建伟,杨劼,贺小红,等.乳腺癌18F-FDG PET/CT和3.0T MRI联合显像评分与Ki-67表达水平的相关性分析[J].国际放射医学核医学杂志,2013,37(2):84.[doi:10.3760/cma.j.issn.1673-4114.2013.02.006]
YUAN Jian-wei,YANG Jie,HE Xiao-hong,et al.Correlation between combined imaging modalities of 18F-FDG PET/CT and 3.0T MRI and expression of Ki-67 in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):84.[doi:10.3760/cma.j.issn.1673-4114.2013.02.006]
[17]袁建伟,杨劼,贺小红,等.18F-FDG PET/CT与3.0T MRI联合显像在乳腺癌原发病灶诊断中的价值[J].国际放射医学核医学杂志,2013,37(4):199.[doi:10.3760/cma.j.issn.1673-4114.2013.04.003]
YUAN Jian-wei,YANG Jie,HE Xiao-hong,et al.Diagnosis value of 18F-FDG PET/CT and 3.0T MRI combined imaging in detecting the primary focus of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):199.[doi:10.3760/cma.j.issn.1673-4114.2013.04.003]
[18]林美福,陈文新,周硕,等.18F-FES PET/CT显像在雌激素受体阳性乳腺癌诊疗中的初步应用[J].国际放射医学核医学杂志,2013,37(4):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
LIN Mei-fu,CHEN Wen-xin,ZHOU Shuo,et al.Application of 18F-FES PET/CT in diagnosis and endocrine therapy of patients with estrogen receptorpositive breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
[19]樊孝廉,鲁胜男,古炎发,等.乳腺癌患者骨病灶SPECT/CT融合显像的临床价值[J].国际放射医学核医学杂志,2013,37(4):221.[doi:10.3760/cma.j.issn.1673-4114.2013.04.008]
FAN Xiao-lian,LU Sheng-nan,GU Yan-fa,et al.The clinical value of SPECT/CT fusion imaging in the diagnosis of bone metastasis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):221.[doi:10.3760/cma.j.issn.1673-4114.2013.04.008]
[20]柳杰,刘佩芳.乳腺癌X射线征象与雌激素受体、孕激素受体和C-erbB-2表达相关性的研究进展[J].国际放射医学核医学杂志,2012,36(5):301.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.009]
LIU Jie LIU,Pei-fang.Development of the correlation study between mammographic appearances and expression of estrogen receptor, progesterone receptor and C-erbB-2 in patients with breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(4):301.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.009]